Moreover, through GEPIA (http://gepia.cancer-pku.cn/), we discovered that the expression of NR3C2 was significantly downregulated in GBM samples compared with the normal tissues (Fig. 3b). The gene discussed is NR3C2; the disease is glioblastoma.